Germline mutations in POLE and POLD1 are linked to variable cancer risks, with findings highlighting mutation-specific differences that refine tumor predisposition assessment.
Researchers examined celiac disease, SLE, MS, and T1D in relation to cancers of the pancreas, stomach, esophagus, small intestine, colon, rectum, liver, and gallbladder.
Higher diversity and quantity of dietary flavonoid intake were each linked to reduced risks of mortality and major chronic diseases in a large population-based study.
Researchers compare long-term outcomes of two biologics in managing Crohn’s disease of the pouch, focusing on clinical response, remission rates, and adverse event profiles in a real-world multicenter setting.